Bone Morphogenetic Protein-2, but Not Mesenchymal Stromal Cells, Exert Regenerative Effects on Canine and Human Nucleus Pulposus Cells

Autor: Bach, Frances, Miranda-Bedate, Alberto, van Heel, Ferdi, Riemers, Frank, Muller, Margot, Creemers, Laura, Ito, Keita, Benz, Karin, Meij, Björn, Tryfonidou, M, Orthopedie en neurochirurgie, LS Equine Muscoskeletal Biology, Biochemisch laboratorium, LS Algemene chirurgie, dCSCA RMSC-1, dES RMSC
Přispěvatelé: Orthopedie en neurochirurgie, LS Equine Muscoskeletal Biology, Biochemisch laboratorium, LS Algemene chirurgie, dCSCA RMSC-1, dES RMSC, Orthopaedic Biomechanics
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
Male
Pathology
medicine.medical_specialty
animal structures
medicine.medical_treatment
Biomedical Engineering
Bone Morphogenetic Protein 2
Bioengineering
Smad2 Protein
Bone morphogenetic protein 2
Biochemistry
Smad1 Protein
Glycosaminoglycan
Transforming Growth Factor beta1
Biomaterials
03 medical and health sciences
Basal (phylogenetics)
0302 clinical medicine
Chondrocytes
Dogs
transforming growth factor beta-1
medicine
Animals
Humans
Regeneration
Chemistry
Growth factor
Mesenchymal stem cell
Intervertebral disc
Mesenchymal Stem Cells
Middle Aged
Cell biology
030104 developmental biology
medicine.anatomical_structure
embryonic structures
Female
bone morphogenetic protein-2
intervertebral disc
mesenchymal stromal cells
Nucleus
Chondrogenesis
030217 neurology & neurosurgery
Transforming growth factor
Zdroj: Tissue Engineering. Part A, 23(5-6), 233. Mary Ann Liebert inc
Tissue Engineering. Part A, 23(5-6), 233. Mary Ann Liebert Inc.
Tissue engineering. Part A, 23(5-6), 233-242. Mary Ann Liebert Inc.
ISSN: 1937-3341
DOI: 10.1089/ten.tea.2016.0251
Popis: Chronic back pain is related to intervertebral disc (IVD) degeneration and dogs are employed as animal models to develop growth factor- and cell-based regenerative treatments. In this respect, the differential effects of transforming growth factor beta-1 (TGF-β1) and bone morphogenetic protein-2 (BMP2) on canine and human chondrocyte-like cells (CLCs) derived from the nucleus pulposus of degenerated IVDs were studied. Human and canine CLCs were cultured in 3D microaggregates in basal culture medium supplemented with/without TGF-β1 (10 ng/mL) or BMP2 (100 or 250 ng/mL). Both TGF-β1 and BMP2 increased proliferation and glycosaminoglycan (GAG) deposition of human and canine CLCs. TGF-β1 induced collagen type I deposition and fibrotic (re)differentiation, whereas BMP2 induced more collagen type II deposition. In dogs, TGF-β1 induced Smad1 and Smad2 signaling, whereas in humans, it only tended to induce Smad2 signaling. BMP2 supplementation increased Smad1 signaling in both species. This altogether indicates that Smad1 signaling was associated with collagen type II production, whereas Smad2 signaling was associated with fibrotic CLC (re)differentiation. As a step toward preclinical translation, treatment with BMP2 alone and combined with mesenchymal stromal cells (MSCs) was further investigated. Canine male CLCs were seeded in albumin-based hydrogels with/without female bone marrow-derived MSCs (50:50) in basal or 250 ng/mL BMP2-supplemented culture medium. Although the results indicate that a sufficient amount of MSCs survived the culture period, total GAG production was not increased and GAG production per cell was even decreased by the addition of MSCs, implying that MSCs did not exert additive regenerative effects on the CLCs.
Databáze: OpenAIRE